CCN5 and pancreatic neoplasm: Notably, Wu et al. reported that protein phosphate 2A (PP2A) inhibitors inhibit cell growth and migration through suppression of the Wnt/β-catenin pathway, including WISP2, in pancreatic cancer cells [58].